OTCMKTS:ISCNF Isracann Biosciences (ISCNF) Stock Price, News & Analysis → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ISCNF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.0001▼$0.011052-Week Range N/AVolume23,333 shsAverage Volume110,335 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Isracann Biosciences alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Isracann Biosciences Stock (OTCMKTS:ISCNF)Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ISCNF Stock News HeadlinesApril 6, 2023 | finance.yahoo.comIIROC Trading Halt - IPOTApril 6, 2023 | finance.yahoo.comIsracann Biosciences Inc. (ISCNF)April 24, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”October 25, 2022 | seekingalpha.comISCNF Isracann Biosciences Inc.October 13, 2022 | finance.yahoo.comIsracann Biosciences Provides Bi-Weekly Default Status ReportSeptember 28, 2022 | finance.yahoo.comIsracann Bioscience Facilitated Genetics Arrive in IsraelSeptember 14, 2022 | benzinga.comIsracann Bioscience Facilitates Cannabis Genetics Shipment To IsraelSeptember 1, 2022 | msn.comIsracann's Praesidio Expands Its Natural Health Products Distribution Network: Inks Deal With Pure Integrative PharmacyApril 24, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.September 1, 2022 | financialpost.comPraesidio signs distribution agreement with Pure Integrative PharmacyAugust 25, 2022 | proactiveinvestors.comIsracann Biosciences adds Super Bowl MVP Mark Rypien to company advisory boardAugust 23, 2022 | finance.yahoo.comIsracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory BoardAugust 3, 2022 | msn.comCannabis Company Isracann Biosciences Raises $234K In The First Tranche Of Private PlacementAugust 3, 2022 | finance.yahoo.comIsracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private PlacementMay 21, 2022 | msn.comIsracann Biosciences' Subsidiary Praesidio Health Submits NPNs To Health CanadaMay 19, 2022 | finance.yahoo.comIsracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health CanadaApril 15, 2022 | financialpost.comIsracann Biosciences Renews Leadership to Meet Changing DemandsApril 14, 2022 | seekingalpha.comIsracann Biosciences acquires Praesidio Health and appoints products officersApril 14, 2022 | msn.comIsracann Biosciences Acquires Praesidio Health And Appoints Natural Health Products OfficersApril 13, 2022 | finance.yahoo.comIsracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products OfficersMarch 28, 2022 | msn.comIsracann Biosciences Signs Definitive Agreement To Acquire Praesidio Health For $3.18MMarch 28, 2022 | seekingalpha.comIsracann Biosciences to acquire Canadian natural health medicine developerMarch 28, 2022 | finance.yahoo.comIsracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine DeveloperFebruary 24, 2022 | finance.yahoo.comUPDATE - Isracann Signs LOI to Acquire Natural Health Medicine DeveloperFebruary 23, 2022 | seekingalpha.comIsracann to acquire natural health medicine developerFebruary 23, 2022 | msn.comIsracann To Acquire Natural Health Medicine Developer Praesidio Health For $3.14MFebruary 23, 2022 | financialpost.comIsracann Signs LOI to Acquire Natural Health Medicine DeveloperSee More Headlines Receive ISCNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Isracann Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:ISCNF CUSIPN/A CIKN/A Webwww.isracann.com Phone604-394-2551FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesAjay Singh KailaInterim Chief Executive OfficerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors ISCNF Stock Analysis - Frequently Asked Questions How do I buy shares of Isracann Biosciences? Shares of ISCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ISCNF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Isracann Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
